PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Shares of PetMed Express, Inc. (NASDAQ:PETS) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.38 and traded as high as $4.53. PetMed Express shares last traded at $4.49, with a volume of 204,635 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered PetMed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, February 11th.

PetMed Express Price Performance

The business has a 50 day moving average price of $4.85 and a 200 day moving average price of $4.38. The firm has a market capitalization of $92.75 million, a P/E ratio of 449.45 and a beta of 0.70.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. As a group, equities analysts expect that PetMed Express, Inc. will post 0.19 EPS for the current year.

Insider Transactions at PetMed Express

In other news, Director Leslie C.G. Campbell acquired 15,000 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was purchased at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the transaction, the director now directly owns 70,000 shares in the company, valued at $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On PetMed Express

Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC grew its position in shares of PetMed Express by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 224,788 shares of the company’s stock valued at $1,084,000 after purchasing an additional 3,558 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of PetMed Express by 2.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 216,812 shares of the company’s stock worth $1,045,000 after purchasing an additional 4,410 shares in the last quarter. American Century Companies Inc. raised its stake in shares of PetMed Express by 15.3% during the 4th quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock worth $162,000 after purchasing an additional 4,459 shares in the last quarter. Squarepoint Ops LLC raised its stake in PetMed Express by 41.4% in the 4th quarter. Squarepoint Ops LLC now owns 17,686 shares of the company’s stock valued at $85,000 after acquiring an additional 5,180 shares during the period. Finally, Northern Trust Corp raised its stake in PetMed Express by 13.2% in the 4th quarter. Northern Trust Corp now owns 51,116 shares of the company’s stock valued at $246,000 after acquiring an additional 5,953 shares during the period. 73.33% of the stock is currently owned by institutional investors and hedge funds.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.